Additional excipient justification [Dissolution / BCS / IVIVC]

posted by Dr_Dan  – Germany, 2014-12-02 10:34 (3791 d 22:47 ago) – Posting: # 13964
Views: 6,585

Dear all
Some time ago I started a discussion about excipients (see this link) which faded out without result. So I thought this might be a good opportunity to restart. I would like to know if there is a chance to justify a different qualitative composition for a biowaiver if well established excipients are used (Lactose, Microcrystalline Cellulose, Magnesium Stearate, Croscarmellose Sodium, Colloidal Silicon Dioxide, Hydroxypropyl Cellulose Starch, Sodium Starch etc.). My Problem is that you will find an endless number of papers describing an impact of an excipient on a special drug substance. What I need is a rationale that at least for drugs considered for a biowaiver the difference in qualitative composition would not affect the in-vivo performance as long as in vitro dissolution tests show similarity between the test product and the reference.
Do you have an idea? I am looking Forward to your reply.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,684 registered users;
22 visitors (0 registered, 22 guests [including 9 identified bots]).
Forum time: 10:21 CEST (Europe/Vienna)

It is true that many scientists are not philosophically minded
and have hitherto shown much skill and ingenuity
but little wisdom.    Max Born

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5